phase readout
saveNCT03066206: Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC
TERMINATEDupdated 2h ago
community read0 votes
Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: EGFR Exon 20 Mutation, ERBB2 Gene Mutation, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Non-Small Cell Lung Cancer AJCC v7
view source ↗
comments(0)
5-min edit window · permanent after that